Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.

Monique Tröbs Stephan AchenbachHolger M NefTomasso GoriChristoph NaberTill NeumannGert RichardtAxel SchmermundJochen WöhrleRalf ZahnChristian W Hammnull null

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)

Real-world 2-year event rates after coronary revascularization with BVS are not significantly different between individuals with ACS as compared to stable CAD.

Keyphrases

acute coronary syndrome
coronary artery disease
percutaneous coronary intervention
coronary artery bypass grafting
antiplatelet therapy
tissue engineering
coronary artery
aortic stenosis
left ventricular